Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a novel psoriasis susceptibility locus

被引：0
|
作者：
Merleev, A. [1 ]
Toussi, A. [1 ]
Downing, L. [1 ]
Tran, M. [1 ]
Nava, J. [1 ]
Le, S. [1 ]
Marusina, A. [1 ]
机构：
[1] Univ Calif Davis, Dermatol, Sacramento, CA 95817 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2021年 / 141卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
005
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [21] Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
    O'Connell, Emma M.
    Lohoff, Falk W.
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [22] Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer
    Bhattacharya, Anindita
    Chowdhury, Abhirup
    Chaudhury, Koel
    Shukla, Praphulla Chandra
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (01):
  • [23] Involvement of proprotein convertase subtilisin/kexin type 9 (PCSK9) in aortic valvular calcification
    Poggio, P.
    Songia, P.
    Chiesa, M.
    Barbieri, S.
    Moschetta, D.
    Valerio, V.
    Cavallotti, L.
    Ferri, N.
    Zanotti, I.
    Camera, M.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1057 - 1057
  • [24] Proprotein Convertase Subtilisin Kexin9 (PCSK9): A Novel Target For Cholesterol Regulation
    Basak, Ajoy
    Palmer-Smith, Heather
    Mishra, Priyambada
    PROTEIN AND PEPTIDE LETTERS, 2012, 19 (06): : 575 - 585
  • [25] Novel Domain Interaction Regulates Secretion of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Protein
    Du, Fen
    Hui, Yvonne
    Zhang, Michelle
    Linton, MacRae F.
    Fazio, Sergio
    Fan, Daping
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (50) : 43054 - 43061
  • [26] The role of proprotein convertase subtilisin kexin 9 (PCSK9) in preeclampsia with severe features
    Bishop, Juliet
    Shaddeau, Angela
    Darwin, Kristin C.
    Wilson, Tenisha
    Boyer, Theresa
    Debrosse, Alexia
    Sharma, Garima
    Vaidya, Dhananjay
    Ouyang, Pamela
    Mukherjee, Monica
    Zakaria, Sammy
    Leucker, Thorsten
    Vaught, Arthur J.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S546 - S547
  • [27] Association of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) With Cardiovascular Risk in Primary Prevention
    Zhu, Yiming M.
    Anderson, Todd J.
    Sikdar, Khokan
    Fung, Marinda
    McQueen, Matthew J.
    Lonn, Eva M.
    Verma, Subodh
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (10) : 2254 - 2259
  • [28] Plasma Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) in the Acute Respiratory Distress Syndrome
    Metkus, Thomas S.
    Kim, Bo Soo
    Jones, Steven R.
    Martin, Seth S.
    Schulman, Steven P.
    Leucker, Thorsten M.
    FRONTIERS IN MEDICINE, 2022, 9
  • [29] PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) LEVEL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN RUSSIA
    Benimetskaya, Kseniya
    Ragino, Yulia
    Shakhtshneider, Elena
    Makarenkova, Kseniya
    Stakhneva, Ekaterina
    Astrakov, Sergey
    Shchepina, Yulia
    Voevoda, Mikhail
    ATHEROSCLEROSIS, 2017, 263 : E195 - E195
  • [30] Antitumor activity and molecular mechanism of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition
    Sun, Huimin
    Meng, Wen
    Zhu, Jie
    Wang, Lu
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (06) : 643 - 658
12345